US › Healthcare

Cardio Diagnostics Holdings Inc (CDIO)

US · Healthcare · Biotechnology

$2.03+1.50%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$5,360

Revenue YoY

-28.3%

Net profit

$-1.5M

EPS

$-0.51

Net margin

-28,012.5%

Key statistics

Market cap

$5.9M

Forward P/E

0.0

P/B

0.82

Book value

$2.51

EPS (TTM)

$-2.90

52-week high

$7.91

52-week low

$0.97

50-day MA

$1.83

200-day MA

$2.26

Beta

2.23

Analyst view

Analysts rate Cardio Diagnostics Holdings Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $60.00.

Shareholding

Insiders

8.31%

Institutions

6.52%

Largest institutional holders

Fund	Stake
Jane Street Group LLC	2.75%
HRT FINANCIAL LLC	2.11%
BlackRock Inc	1.17%
Geode Capital Management, LLC	1.09%
Vanguard Capital Management, LLC	0.68%
Citadel Advisors Llc	0.64%
Renaissance Technologies Corp	0.52%
Scientech Research LLC	0.47%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cardio Diagnostics Holdings Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.